- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes Following Radical Cystectomy.
September 10, 2020
New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives.
September 10, 2020
Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future.
September 10, 2020
TFPI-2 inhibits the invasion and metastasis of bladder cancer cells.
September 10, 2020
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer.
September 9, 2020
miR-211-5p is downregulated and a prognostic marker in bladder cancer.
September 9, 2020
Impact of Perioperative Multidisciplinary Rehabilitation Pathway on Early Outcomes after Robot-Assisted Radical Cystectomy: A Matched Analysis.
September 9, 2020
Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect.
September 8, 2020
Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
September 8, 2020
Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging-reporting and data system.
September 8, 2020
Gamma/Delta T-Cells Enhance Carboplatin-induced Cytotoxicity Towards Advanced Bladder Cancer Cells.
September 7, 2020
Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer.
September 7, 2020
Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer.
September 7, 2020